|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/18/24 STAAR Surgical Co. 8-K:7,8,9 3/18/24 10:12M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 8-K Current Report HTML 45K
2: EX-99.1 Miscellaneous Exhibit HTML 27K
3: EX-99.2 Miscellaneous Exhibit HTML 16K
5: R1 Document And Entity Information HTML 45K
7: XML IDEA XML File -- Filing Summary XML 11K
10: XML XBRL Instance -- staa-20240318_htm XML 15K
6: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
4: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 85K
Linkbases Document -- staa-20240318
8: JSON XBRL Instance as JSON Data -- MetaLinks 12± 19K
9: ZIP XBRL Zipped Folder -- 0000950170-24-032512-xbrl Zip 26K
| 8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
i Date of report (Date of earliest event reported): i March 18, 2024
i STAAR Surgical Company
(Exact Name of Registrant as Specified in Charter)
i Delaware |
i 0-11634 |
i 95-3797439 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
i 25651 Atlantic Ocean Drive., i Lake Forest, i California |
|
i 92630 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: i 626- i 303-7902
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i ☐ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ |
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ |
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
i Common |
i STAA |
i NASDAQ |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
Representatives of STAAR Surgical Company (the “Company”) will give presentations to investors commencing on March 18, 2024. A copy of the slide presentation they will share is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by this reference.
Item 8.01 Other Events.
On March 18, 2024, the Company issued a press release reporting that more than three million of the Company's Implantable Collamer® Lenses (“ICLs”) have been sold globally, a copy of which is furnished as Exhibit 99.2 to this Current Report and is incorporated herein by this reference.
The information furnished herewith pursuant to Items 7.01 and 8.01 of this Current Report, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Items 7.01 and 8.01 of this Current Report, and Exhibits 99.1 and 99.2, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. |
|
Description |
|
|
|
99.1 |
|
|
|
|
|
99.2 |
|
|
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
STAAR Surgical Company |
||
|
||
By: |
/s/ Tom Frinzi |
|
|
|
Thomas Frinzi |
|
|
President and Chief Executive Officer |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 3/18/24 | None on these Dates | ||
| List all Filings | ||||